X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/nanoform-and-plusvitech-partner-to-repurpose-aprepitant-as-a-treatment-for-lung-cancer-302111314.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-intravenous-emulsion-43936.pdf
https://www.fiercepharma.com/pharma/heron-scores-fda-go-ahead-aponvie-iv-alternative-pills-postoperative-nausea
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-1655269712.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-azilsartan-bupivacaine-cladribine-elrombopag-fosnetupitant-fostamatinib-ivacaftor-and-sodium-thiosulfate-1655270821.pdf
https://www.prnewswire.com/news-releases/heron-therapeutics-announces-submission-of-htx-019-nda-for-the-prevention-of-postoperative-nausea-and-vomiting-to-fda-301427958.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211835
https://www.prnewswire.com/news-releases/heron-therapeutics-announces-initiation-of-phase-2-clinical-study-of-cinvanti-for-the-treatment-of-covid-19-301094550.html
https://www.prnewswire.com/news-releases/heron-announces-fda-approval-of-supplemental-new-drug-application-to-expand-cinvanti-label-for-iv-push-300802594.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-26-2018-1545811500.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207777
http://www.fiercebiotech.com/story/facing-rivals-merck-looks-expand-cinv-label-positive-phiii-emend-study/2015-06-29
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
Market Place
Share 
